Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ellison

Showing results (521-530 of 574) with videos related to

Pageof 58
Sort By:
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional TrialsSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Pageof 58

Showing results (521-530 of 574) with videos related to

Sort By:
Pageof 58
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional TrialsSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Cancer Cell|October 22, 2021
Serial assessment of measurable residual disease in medulloblastoma liquid biopsiesAnthony P Y Liu, Kyle S Smith, Rahul Kumar, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Brain Pathology (Zurich, Switzerland)|December 15, 2019
Clinicopathologic and molecular features of intracranial desmoplastic small round cell tumorsJulieann C Lee, Javier E Villanueva-Meyer, Sean P Ferris, et al.
Pageof 58